| Stage | LESL | % of rev | ULTA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $458M | 100.00% | $3.0B | 100.00% | ULTA ×6.62 |
| Gross profit | $167M | 36.45% | $1.2B | 39.10% | ULTA +2.6pp |
| Operating income | $61M | 13.41% | $380M | 12.51% | LESL +0.9pp |
| Pre-tax income | $47M | 10.32% | $376M | 12.38% | ULTA +2.1pp |
| Net income | $48M | 10.42% | $282M | 9.29% | LESL +1.1pp |
| Stage | LESL | ULTA | Gap · A − B |
|---|---|---|---|
| Revenue | $458M100.00% | $3.0B100.00% | ULTA ×6.62 |
| Gross profit | 36.45%$167M | 39.10%$1.2B | ULTA +2.6pp |
| Operating income | 13.41%$61M | 12.51%$380M | LESL +0.9pp |
| Pre-tax income | 10.32%$47M | 12.38%$376M | ULTA +2.1pp |
| Net income |
| 10.42%$48M |
| 9.29%$282M |
| LESL +1.1pp |
None
No disclosed counterparties: LESL.